Amit Sachdev Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 4 hours ago
Amit Sachdev has an estimated net worth of at least $41.1 million*, as of April 9, 2025. They own 72,193 shares of VRTX stock. They have sold 20,816 shares of VRTX stock since 2021, for an estimated $8.0 million.
Amit Sachdev $VRTX SEC Form 4 Insider Trading
Amit Sachdev has filed a total of 8 insider trades in $VRTX since 2021. Their most recent trade was a sale of 32 shares, made on May 15, 2024. Their largest trade was a sale of 10,031 shares, made on Aug 10, 2023. We estimate that they now own 72,193 shares of $VRTX, worth an estimated $33.0 million.
Insider Trading at $VRTX
There have been a total of 493 insider trades reported at $VRTX since 2021, with 25,000 shares purchased and 847,189 shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Bastiano Sanna, and Ourania Tatsis. The most recent trade was a sale of 3,231 shares reported by DAVID ALTSHULER (EVP, Chief Scientific Officer), made on Mar 13, 2025.
History of Insider Stock Trades by Amit Sachdev
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 32 | May 15, 2024 | May 17, 2024, 4:27 p.m. |
|
VRTX
|
Sale | 3,191 | Feb 21, 2024 | Feb. 23, 2024, 5:20 p.m. |
|
VRTX
|
Sale | 4,254 | Feb 20, 2024 | Feb. 21, 2024, 5:38 p.m. |
|
VRTX
|
Sale | 3,222 | Feb 12, 2024 | Feb. 13, 2024, 6:15 p.m. |
|
VRTX
|
Sale | 35 | Nov 15, 2023 | Nov. 17, 2023, 5:16 p.m. |
|
VRTX
|
Sale | 10,031 | Aug 10, 2023 | Aug. 14, 2023, 4:05 p.m. |
|
VRTX
|
Sale | 21 | Nov 15, 2021 | Nov. 16, 2021, 5:07 p.m. |
|
VRTX
|
Sale | 30 | Nov 15, 2021 | Nov. 16, 2021, 5:07 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Stuart A Arbuckle, EVP, COO
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Jeffrey M Leiden, Executive Chairman
-
Joy Liu, SVP, General Counsel
-
Reshma Kewalramani, CEO & President
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Carmen Bozic, EVP and CMO
-
David Altshuler, EVP, Chief Scientific Officer
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Jonathan Biller, EVP and Chief Legal Officer
-
Amit Sachdev, EVP, Chief Patient Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.